The integration of Isto Technologies and Arteriocyte Medical Systems will expand best-in-class product portfolios and build upon both companies' deep scientific expertise in biologics and cell therapy to provide better patient outcomes
Isto Biologics was formed in 2016 when -based Isto Technologies and Arteriocyte Medical Systems Inc. of , integrated under the Isto Holdings umbrella. Isto Biologics is focused on offering evidence-based solutions for bone regeneration and cell therapy to help improve patient outcomes. The company's best-in-class product offerings include Arteriocyte's market-leading MAGELLAN® Autologous Platelet Separator and Isto's bone-growth and cell-therapy products including InQu® Bone Graft Extender & Substitute; Influx®, a natural bone-graft material; and CellPoint®, a concentrated bone marrow aspirate system. For more information, visit istobiologics.com.
Director of Marketing